Assessment of columnar-lined esophagus in controls and patients with gastroesophageal reflux disease with and without proton-pump inhibitor therapy

被引:0
|
作者
I. Mesteri
J. Lenglinger
L. Beller
S. Fischer-See
Sebastian F. Schoppmann
F. Wrba
F. M. Riegler
J. Zacherl
机构
[1] Medical University of Vienna,Department of Surgery
[2] Medical University of Vienna,Institute for Clinical Pathology
来源
European Surgery | 2012年 / 44卷
关键词
Barrett’s esophagus; Columnar-lined esophagus; Endoscopy; Dilated distal esophagus; Gastroesophageal reflux disease; Histopathology; Squamooxyntic gap;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:304 / 313
页数:9
相关论文
共 50 条
  • [31] Frequency scale for symptoms of gastroesophageal reflux disease questionnaire predicts requirement of proton pump inhibitor maintenance therapy
    Miyamoto, Masaki
    Manabe, Noriaki
    Haruma, Ken
    ESOPHAGUS, 2010, 7 (03) : 143 - 149
  • [32] Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett's esophagus
    Baldaque-Silva, Francisco
    Vieth, Michael
    Debel, Mumen
    Hakanson, Bengt
    Thorell, Anders
    Lunet, Nuno
    Song, Huan
    Mascarenhas-Saraiva, Miguel
    Pereira, Gisela
    Lundell, Lars
    Marschall, Hanns-Ulrich
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (17) : 3174 - 3183
  • [33] Frequency scale for symptoms of gastroesophageal reflux disease questionnaire predicts requirement of proton pump inhibitor maintenance therapy
    Masaki Miyamoto
    Noriaki Manabe
    Ken Haruma
    Esophagus, 2010, 7 : 143 - 149
  • [34] Gastroesophageal reflux disease in primary care: Using changes in proton pump inhibitor therapy as an indicator of partial response
    Ruigomez, Ana
    Johansson, Saga
    Wernersson, Boerje
    Fernandez Cantero, Oscar
    Garcia Rodriguez, Luis A.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (07) : 751 - 761
  • [35] Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors
    Tonini, M.
    Vigneri, S.
    Neri, M.
    Cuomo, R.
    Savarino, V.
    Pace, F.
    DIGESTION, 2007, 76 (3-4) : 171 - 178
  • [36] Gastroesophageal Reflux Disease Symptom Severity, Proton Pump Inhibitor Use, and Esophageal Carcinogenesis
    Nason, Katie S.
    Wichienkuer, Promporn Paula
    Awais, Omar
    Schuchert, Matthew J.
    Luketich, James D.
    O'Rourke, Robert W.
    Hunter, John G.
    Morris, Cynthia D.
    Jobe, Blair A.
    ARCHIVES OF SURGERY, 2011, 146 (07) : 851 - 858
  • [37] Effect of a Preoperative Proton Pump Inhibitor and Gastroesophageal Reflux Disease on Postoperative Nausea and Vomiting
    Kwon, Young Suk
    Choi, Jun Woo
    Lee, Ho Seok
    Kim, Jong Ho
    Kim, Youngmi
    Lee, Jae Jun
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [38] Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett's esophagus
    Francisco Baldaque-Silva
    Michael Vieth
    Mumen Debel
    Bengt H?kanson
    Anders Thorell
    Nuno Lunet
    Huan Song
    Miguel Mascarenhas-Saraiva
    Gisela Pereira
    Lars Lundell
    Hanns-Ulrich Marschall
    World Journal of Gastroenterology, 2017, 23 (17) : 3174 - 3183
  • [39] Value of the Gastroesophageal Reflux Disease Questionnaire (GerdQ) in predicting the proton pump inhibitor response in coronary artery disease patients with gastroesophageal reflux-related chest pain
    He, S.
    Liu, Y.
    Chen, Y.
    Tang, Y.
    Xu, J.
    Tang, C.
    DISEASES OF THE ESOPHAGUS, 2016, 29 (04) : 367 - 376
  • [40] Rikkunshito improves globus sensation in patients with proton-pump inhibitor-refractory laryngopharyngeal reflux
    Ryoji Tokashiki
    Isaku Okamoto
    Nobutoshi Funato
    Mamoru Suzuki
    World Journal of Gastroenterology, 2013, (31) : 5118 - 5124